+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Asia Pacific Meningococcal Vaccine Market By Brand, By Type, By Age Group, By Country, Industry Analysis and Forecast, 2020 - 2026

  • ID: 5241353
  • Report
  • January 2021
  • Region: Asia Pacific
  • 79 pages
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
1 of 4

FEATURED COMPANIES

  • Bio-Med Pvt. Ltd.
  • GlaxoSmithKline PLC (GSK)
  • Pfizer, Inc.
  • Sanofi S.A.
  • MORE
The Asia Pacific Meningococcal Vaccine Market is expected to witness market growth of 9.9% CAGR during the forecast period (2020-2026).

Meningococcal vaccine manufacturers are focusing on the Asia Pacific region in order to capitalize for broadening treatment options for meningococcal disease in the region. As polysaccharide vaccines continue to show high traction from emerging countries owing to limited supply by limited vaccine manufacturers. That is why market forerunners team up with local distributors in order to expand their footprint. Furthermore, key market players, such as GlaxoSmithKline Plc., are capitalizing more to widening the range of age covered by meningococcal vaccines in the market.

The transmission of meningococcal bacteria, and unpredictable occurrences over time and across different age groups and geographies, have resulted in a substantial increase in the number of clinical programs for the effective development of meningococcal vaccines across the globe. Presently, around 30 ongoing clinical programs for the development of meningococcal vaccines at different stages. In the context of increasing government initiatives towards the development of meningococcal vaccines, the potential demand for these vaccines has increased.

Based on Brand, the market is segmented into Bexsero, Trumenba, Nimenrix, Menactra, Menveo and Other Brands. Based on Type, the market is segmented into Bivalent, Quadrivalent and Other Types. Based on Age Group, the market is segmented into Infants (0 to 2 years) and Children (2 years & above). Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include GlaxoSmithKline PLC (GSK), Pfizer, Inc., Sanofi S.A., Walvax Biotechnology Co., Ltd., Bio-Manguinhos (Oswaldo Cruz Foundation), Bio-Med Pvt. Ltd., Chongqing Zhifei Biological Products Co., Ltd., Hualan Biological Engineering, Inc., Incepta Pharmaceuticals Ltd. and Serum Institute of India Pvt. Ltd. (Poonawalla Investments & Industries Pvt. Ltd.)

Scope of the Study

Market Segments covered in the Report:

By Brand
  • Bexsero
  • Trumenba
  • Nimenrix
  • Menactra
  • Menveo
  • Other Brands
By Type
  • Bivalent
  • Quadrivalent
  • Other Types
By Age Group
  • Infants (0 to 2 years)
  • Children (2 years & above)
By Country
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
Companies Profiled
  • GlaxoSmithKline PLC (GSK)
  • Pfizer, Inc.
  • Sanofi S.A.
  • Walvax Biotechnology Co., Ltd.
  • Bio-Manguinhos (Oswaldo Cruz Foundation)
  • Bio-Med Pvt. Ltd.
  • Chongqing Zhifei Biological Products Co., Ltd.
  • Hualan Biological Engineering, Inc.
  • Incepta Pharmaceuticals Ltd.
  • Serum Institute of India Pvt. Ltd. (Poonawalla Investments & Industries Pvt. Ltd.)
Unique Offerings from the Publisher
  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Bio-Med Pvt. Ltd.
  • GlaxoSmithKline PLC (GSK)
  • Pfizer, Inc.
  • Sanofi S.A.
  • MORE
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Meningococcal Vaccine Market, by Brand
1.4.2 Asia Pacific Meningococcal Vaccine Market, by Type
1.4.3 Asia Pacific Meningococcal Vaccine Market, by Age Group
1.4.4 Asia Pacific Meningococcal Vaccine Market, by Country
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market composition and scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Recent Developments in Meningococcal Vaccine Market

Chapter 4. Asia Pacific Meningococcal Vaccine Market by Brand
4.1 Asia Pacific Bexsero Market by Country
4.2 Asia Pacific Trumenba Market by Country
4.3 Asia Pacific Nimenrix Market by Country
4.4 Asia Pacific Menactra Market by Country
4.5 Asia Pacific Menveo Market by Country
4.6 Asia Pacific Other Brands Market by Country

Chapter 5. Asia Pacific Meningococcal Vaccine Market by Type
5.1 Asia Pacific Bivalent Market by Country
5.2 Asia Pacific Quadrivalent Market by Country
5.3 Asia Pacific Other Types Market by Country

Chapter 6. Asia Pacific Meningococcal Vaccine Market by Age Group
6.1 Asia Pacific Children (2 years & above) and Adults Market by Country
6.2 Asia Pacific Infants(0 to 2 years) Market by Country

Chapter 7. Asia Pacific Meningococcal Vaccine Market by Country
7.1 China Meningococcal Vaccine Market
7.1.1 China Meningococcal Vaccine Market by Brand
7.1.2 China Meningococcal Vaccine Market by Type
7.1.3 China Meningococcal Vaccine Market by Age Group
7.2 India Meningococcal Vaccine Market
7.2.1 India Meningococcal Vaccine Market by Brand
7.2.2 India Meningococcal Vaccine Market by Type
7.2.3 India Meningococcal Vaccine Market by Age Group
7.3 Japan Meningococcal Vaccine Market
7.3.1 Japan Meningococcal Vaccine Market by Brand
7.3.2 Japan Meningococcal Vaccine Market by Type
7.3.3 Japan Meningococcal Vaccine Market by Age Group
7.4 South Korea Meningococcal Vaccine Market
7.4.1 South Korea Meningococcal Vaccine Market by Brand
7.4.2 South Korea Meningococcal Vaccine Market by Type
7.4.3 South Korea Meningococcal Vaccine Market by Age Group
7.5 Singapore Meningococcal Vaccine Market
7.5.1 Singapore Meningococcal Vaccine Market by Brand
7.5.2 Singapore Meningococcal Vaccine Market by Type
7.5.3 Singapore Meningococcal Vaccine Market by Age Group
7.6 Malaysia Meningococcal Vaccine Market
7.6.1 Malaysia Meningococcal Vaccine Market by Brand
7.6.2 Malaysia Meningococcal Vaccine Market by Type
7.6.3 Malaysia Meningococcal Vaccine Market by Age Group
7.7 Rest of Asia Pacific Meningococcal Vaccine Market
7.7.1 Rest of Asia Pacific Meningococcal Vaccine Market by Brand
7.7.2 Rest of Asia Pacific Meningococcal Vaccine Market by Type
7.7.3 Rest of Asia Pacific Meningococcal Vaccine Market by Age Group

Chapter 8. Company Profiles
8.1 GlaxoSmithKline PLC (GSK)
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expense
8.1.5 Recent strategies and developments:
8.1.5.1 Approvals:
8.2 Pfizer, Inc.
8.2.1 Company Overview
8.2.1 Financial Analysis
8.2.2 Segmental and Regional Analysis
8.2.3 Recent strategies and developments:
8.2.3.1 Approvals:
8.3 Sanofi S.A.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expense
8.3.5 Recent strategies and developments:
8.3.5.1 Approvals:
8.4 Walvax Biotechnology Co., Ltd.
8.4.1 Company Overview
8.5 Bio-Manguinhos (Oswaldo Cruz Foundation)
8.5.1 Company Overview
8.5.2 Recent strategies and developments:
8.5.2.1 Partnerships, Collaborations, and Agreements:
8.6 Bio-Med Pvt. Ltd.
8.6.1 Company Overview
8.7 Chongqing Zhifei Biological Products Co., Ltd.
8.7.1 Company Overview
8.8 Hualan Biological Engineering, Inc.
8.8.1 Company Overview
8.9 Incepta Pharmaceuticals Ltd.
8.9.1 Company Overview
8.10. Serum Institute of India Pvt. Ltd. (Poonawalla Investments & Industries Pvt. Ltd.)
8.10.1 Company Overview
8.10.2 Recent strategies and developments:
8.10.2.1 Product Launches and Product Expansions:
Note: Product cover images may vary from those shown
3 of 4
  • GlaxoSmithKline PLC (GSK)
  • Pfizer, Inc.
  • Sanofi S.A.
  • Walvax Biotechnology Co., Ltd.
  • Bio-Manguinhos (Oswaldo Cruz Foundation)
  • Bio-Med Pvt. Ltd.
  • Chongqing Zhifei Biological Products Co., Ltd.
  • Hualan Biological Engineering, Inc.
  • Incepta Pharmaceuticals Ltd.
  • Serum Institute of India Pvt. Ltd. (Poonawalla Investments & Industries Pvt. Ltd.)
Note: Product cover images may vary from those shown
4 of 4

Loading
LOADING...

Adroll
adroll